Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 348 entries
View as:

Study of the Safety and Efficacy of REGN475(SAR164877) in Patients With Pain Resulting From Thermal Injury

Phase: N/A Priority: Normal
NCT ID: NCT01053702 Org: User:
Start: - End: - Due: -

Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04154943 Org: User:
Start: 03/10/20 End: 09/05/25 Due: 09/05/26

A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies

Phase: N/A Priority: Normal
NCT ID: NCT03888105 Org: User:
Start: 11/13/19 End: 12/21/29 Due: 12/21/30

Post-authorization Safety Study in North America to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT04173442 Org: User:
Start: 10/24/18 End: 01/30/26 Due: 01/30/27

REGN5381 in Adult Participants With Heart Failure With Reduced Ejection Fraction

Phase: N/A Priority: Normal
NCT ID: NCT06237309 Org: User:
Start: 04/11/24 End: 04/15/26 Due: 04/15/27

A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06097364 Org: User:
Start: 11/14/23 End: 07/29/29 Due: 07/29/30

A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers

Phase: N/A Priority: Normal
NCT ID: NCT04626635 Org: User:
Start: 12/21/20 End: 12/12/26 Due: 12/12/27

Study Utilizing Rilonacept in Gout Exacerbations

Phase: N/A Priority: Normal
NCT ID: NCT00855920 Org: User:
Start: 03/31/09 End: 02/28/10 Due: 02/28/11

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Phase: N/A Priority: Normal
NCT ID: NCT06246916 Org: User:
Start: 09/09/24 End: 07/10/33 Due: 07/10/34

A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

Phase: N/A Priority: Normal
NCT ID: NCT06379789 Org: User:
Start: 09/11/24 End: 12/17/32 Due: 12/17/33

Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)

Phase: N/A Priority: Normal
NCT ID: NCT01722045 Org: User:
Start: 11/30/12 End: 09/30/15 Due: 09/30/16

Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)

Phase: N/A Priority: Normal
NCT ID: NCT02612454 Org: User:
Start: 10/15/15 End: 10/07/26 Due: 10/07/27

A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC)

Phase: N/A Priority: Normal
NCT ID: NCT06299111 Org: User:
Start: 09/20/24 End: 06/08/26 Due: 06/08/27

A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT05785767 Org: User:
Start: 06/30/23 End: 02/05/32 Due: 02/05/33

A Study of REGN7544 for the Treatment in Adult Patients With Sepsis-Induced Hypotension

Phase: N/A Priority: Normal
NCT ID: NCT06608901 Org: User:
Start: 05/05/25 End: 10/19/26 Due: 10/19/27

Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of REGN3918 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03115996 Org: User:
Start: 05/10/17 End: 08/31/18 Due: 08/31/19

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04426695 Org: User:
Start: 06/10/20 End: 10/22/21 Due: 10/22/22

A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)

Phase: N/A Priority: Normal
NCT ID: NCT05557591 Org: User:
Start: 04/21/23 End: 06/07/27 Due: 06/07/28

COVID-19 Study Assessing the Safety and Tolerability of Co-Formulated Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) in Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05181683 Org: User:
Start: 01/07/22 End: 06/03/22 Due: 06/03/23

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

Phase: N/A Priority: Normal
NCT ID: NCT06292780 Org: User:
Start: 08/07/24 End: 02/20/35 Due: 02/20/36

Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-to-Severe Chronic Low Back Pain and Osteoarthritis of the Hip or Knee

Phase: N/A Priority: Normal
NCT ID: NCT03285646 Org: User:
Start: 10/30/17 End: 05/02/19 Due: 05/02/20

REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma

Phase: N/A Priority: Normal
NCT ID: NCT03690869 Org: User:
Start: 09/24/18 End: 05/10/23 Due: 05/10/24

Efficacy and Safety of Colchicine for the Prevention of Gout Flares During the Initiation of Allopurinol

Phase: N/A Priority: Normal
NCT ID: NCT01451645 Org: User:
Start: 10/31/11 End: 09/30/12 Due: 09/30/13

A Single-Dose Study of the Safety and Tolerability of REGN475(SAR164877) in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00856310 Org: User:
Start: 02/28/09 End: 11/30/09 Due: 11/30/10

A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05133531 Org: User:
Start: 08/01/22 End: 01/28/27 Due: 01/28/28